Helicobacter pylori (H. pylori) infection of the stomach is responsible for significant amount of morbidity and mortality. Although H. pylori have multiple virulence factors, the host response also contributes to pathogenesis and these host factors vary between individuals. In addition to H. py/on-associated diseases, significant morbidity is associated with non-H. pylori associated gastric afflictions. Dyspepsia is the most common gastric ailment among adults and children yet there is no clear association with H. pylori. New genomics evidence on bacterial isolates indicates there are other populations of bacteria in the gastric mucosa. These other bacterial genera or species might help explain why gastric maladies vary between populations and between individuals. They might also serve as an important co-factor in H. py/on-associated diseases. We hypothesize that the gastric mucosa harbors resident populations of non-Helicobacter bacteria that vary among individuals and serve as important cofactors in determining the gastric health of the host. These bacteria, together with the host immune response work cumulatively to influence the incidence and character of gastric malignancies. This hypothesis will be tested by accomplishing the following three specific aims. 1) Compare the immune responses to H. pylori in children and adults undergoing diagnostics for presumptive H. pylori infection. These studies will help us assess the relative importance of the key effector immune responses in influencing the development of H. pylori infection in children and adults. 2. Assess the potential importance of the gastric microbiome in influencing the development and the degree of inflammation associated with H. pylori infection in children and adults. The results from these studies will be correlated with the immune responses in subjects in Aim 1 to determine the association of the gastric microbiome with specific immune responses to H. pylori infection in children and adults. 3. Assess the role of specific immunity and gastric microflora either in isolation or in concert with H. pylori infection, in influencing the development of gastroesophageal reflux disease, dyspepsia, gastric ulcers, duodenal ulcers and gastric cancer. These studies will generate new information about immunologic function and regulation in the stomach which would subsequently allow for comparison to gut immunity. Additionally, new information on the presence and possible contribution of other bacteria on gastric health and disease will provide significant advances for treatment of patients presenting with gastric pathology

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI082655-05
Application #
8485524
Study Section
Special Emphasis Panel (ZAI1-KS-I)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
5
Fiscal Year
2013
Total Cost
$521,372
Indirect Cost
$159,317
Name
University of Maryland Baltimore
Department
Type
DUNS #
188435911
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Haney, Douglas J; Lock, Michael D; Gurwith, Marc et al. (2018) Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection. Vaccine 36:2768-2773
Davis, Courtney L; Wahid, Rezwanul; Toapanta, Franklin R et al. (2018) A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. PLoS One 13:e0189571
Toapanta, Franklin R; Bernal, Paula J; Kotloff, Karen L et al. (2018) T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. J Transl Med 16:61
Zhang, Yan; Brady, Arthur; Jones, Cheron et al. (2018) Compositional and Functional Differences in the Human Gut Microbiome Correlate with Clinical Outcome following Infection with Wild-Type Salmonella enterica Serovar Typhi. MBio 9:
Senger, Stefania; Ingano, Laura; Freire, Rachel et al. (2018) Human Fetal-Derived Enterospheres Provide Insights on Intestinal Development and a Novel Model to Study Necrotizing Enterocolitis (NEC). Cell Mol Gastroenterol Hepatol 5:549-568
Sztein, Marcelo B (2018) Is a Human CD8 T-Cell Vaccine Possible, and if So, What Would It Take? CD8 T-Cell-Mediated Protective Immunity and Vaccination against Enteric Bacteria. Cold Spring Harb Perspect Biol 10:
Salerno-Gonçalves, Rosângela; Tettelin, Hervé; Lou, David et al. (2017) Use of a novel antigen expressing system to study the Salmonella enterica serovar Typhi protein recognition by T cells. PLoS Negl Trop Dis 11:e0005912
Booth, Jayaum S; Patil, Seema A; Ghazi, Leyla et al. (2017) Systemic and Terminal Ileum Mucosal Immunity Elicited by Oral Immunization With the Ty21a Typhoid Vaccine in Humans. Cell Mol Gastroenterol Hepatol 4:419-437
Fresnay, Stephanie; McArthur, Monica A; Magder, Laurence S et al. (2017) Importance ofSalmonellaTyphi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model. Front Immunol 8:208
Salerno-Goncalves, Rosângela; Luo, David; Fresnay, Stephanie et al. (2017) Challenge of Humans with Wild-type Salmonella enterica Serovar Typhi Elicits Changes in the Activation and Homing Characteristics of Mucosal-Associated Invariant T Cells. Front Immunol 8:398

Showing the most recent 10 out of 59 publications